Study on molecular anti-tumor mechanism of 2-thiohydantoin derivative based on molecular docking and bioinformatic analyses
CONCLUSION: The relevance of this 2-thiohydantoin derivative was demonstrated by our experimental tests, docking studies, and bioinformatics analysis, and it may be investigated as a lead molecule for anticancer medicines, notably as AKT1 and CKD2 inhibitors.PMID:36617706 | DOI:10.2174/1568026623666230106121527
Source: Current Topics in Medicinal Chemistry - Category: Chemistry Authors: Ali A A Al-Shawi Amr Ahmed El Arabey Dakhil Zughayir Mutlaq Wafa Ali Eltayb Marcello Iriti Mohnad Abdalla Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Hepatocellular Carcinoma | Immunotherapy | Liver | Liver Cancer | Middle East Health | Study | Urology & Nephrology